Dunedin biotechnology company Botry Zen is on the hunt for capital as it prepares to gear up to meet looming business opportunities.
Discussions were being held with two European companies to distribute and market its anti-fungal product botry zen and a new version for late season use, botry zen II.
Botry zen was trialled during the last Northern Hemisphere growing season in the US, Italy, France and Germany and the results were similar to those achieved in New Zealand.
Botry Zen on the hunt for capital
AdvertisementAdvertise with NZME.